The PROTAC DT2216 Targets Cancer by Promoting BCL-XL Degradation.
Sign Up to like & getrecommendations! Published in 2020 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-rw2019-185
Abstract: DT2216, a proteolysis-targeting chimera (PROTAC), effectively targets BCL-XLfor degradation. read more here.
Keywords: protac; protac dt2216; dt2216 targets; targets cancer ... See more keywords